Shionogi & Co.,Ltd.
4507 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大阪市中央区道修町３丁目１番８号
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Shionogi & Co., Ltd. is a prominent Japanese pharmaceutical company with a rich history spanning over 140 years. Committed to improving the health and well-being of patients globally, Shionogi focuses on innovative drug development and the delivery of transformative therapies. The company prides itself on its passionate workforce, which embodies a longstanding commitment to societal needs and environmental sustainability. By leveraging extensive research and development capabilities, Shionogi aims to address critical healthcare challenges while fostering a healthier planet. As a forward-thinking organization, Shionogi continues to advance its mission of serving patients, society, and the environment through dedicated efforts and sustainable practices.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-19 09:24 |
Inside Information Statement
臨時報告書
|
Japanese | 30.7 KB | |
| 2025-06-19 09:14 |
Internal Control over Financial Reporting
内部統制報告書－第160期(2024/04/01－2025/03/31)
|
Japanese | 30.2 KB | |
| 2025-06-19 09:12 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2025-06-19 09:10 |
Annual Report
有価証券報告書－第160期(2024/04/01－2025/03/31)
|
Japanese | 2.5 MB | |
| 2025-06-19 08:07 |
Regulatory News Service
公開買付報告書
|
Japanese | 41.6 KB | |
| 2025-06-19 06:40 |
Major Shareholding Notification
大量保有報告書
|
Japanese | 61.0 KB | |
| 2025-06-18 08:49 |
Inside Information Statement
臨時報告書
|
Japanese | 41.9 KB | |
| 2025-06-04 08:39 |
Regulatory News Service
訂正公開買付届出書
|
Japanese | 258.4 KB | |
| 2025-05-28 08:38 |
Regulatory News Service
訂正公開買付届出書
|
Japanese | 262.0 KB | |
| 2025-05-08 05:52 |
Regulatory News Service
公開買付届出書
|
Japanese | 530.2 KB | |
| 2025-05-07 09:12 |
Inside Information Statement
臨時報告書
|
Japanese | 50.3 KB | |
| 2024-11-08 02:44 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2024-11-08 02:41 |
Interim Report
半期報告書－第160期(2024/04/01－2025/03/31)
|
Japanese | 320.3 KB | |
| 2024-06-21 08:18 |
Inside Information Statement
臨時報告書
|
Japanese | 27.6 KB | |
| 2024-06-21 04:28 |
Internal Control over Financial Reporting
内部統制報告書－第159期(2023/04/01－2024/03/31)
|
Japanese | 24.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
| Canzon Israel Ltd. | Israel | CNZN | ||
|
Carna Biosciences, Inc. | Japan | 4572 | |
|
CATALYST MEDIA GROUP PLC | United Kingdom | CMX | |
|
Celon Pharma S.A. | Poland | CLN | |
|
Chemical Works of Gedeon Richter Plc | Hungary | RICHT | |
|
Chiome Bioscience Inc. | Japan | 4583 | |
|
Chordia Therapeutics,Inc | Japan | 190A | |
|
CHUGAI PHARMACEUTICAL CO., LTD. | Japan | 4519 | |
|
CHUKYOIYAKUHIN CO.,LTD. | Japan | 4558 | |
|
COSMO Pharmaceuticals N.V. | Netherlands (Kingdom of the) | COPN |